Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,259,699
+$3,278,355 QoQ
Shares Held
11,055
+1.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#1,104
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INGALLS & SNYDER LLC holds $149,411,802 across 12 Drug Manufacturers - General names. LLY ranks #6 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
135,858 | $34,187,307 | |
| 2 | MRK |
Merck & Co., Inc.
|
203,973 | $26,210,530 | |
| 3 | NVS |
Novartis AG
|
134,587 | $21,092,474 | |
| 4 | JNJ |
Johnson & Johnson
|
74,509 | $18,923,050 | |
| 5 | PFE |
Pfizer Inc
|
730,345 | $17,586,707 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
11,055 | $13,259,699 | |
| 7 | AZN |
Astrazeneca PLC
|
29,529 | $5,599,288 | |
| 8 | AMGN |
Amgen Inc
|
14,885 | $5,390,156 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,259,699 | 11,055 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $9,981,344 | 10,852 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $11,289,514 | 10,505 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $8,547,126 | 11,202 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $5,491,009 | 7,044 | Shares | Other | 2025-07-31 | |
| 2025-03-31 | $5,715,297 | 6,920 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $5,305,184 | 6,872 | Shares | Other | 2025-01-29 | |
| 2024-09-30 | $6,203,351 | 7,002 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $6,629,192 | 7,322 | Shares | Other | 2024-07-31 | |
| 2024-03-31 | $5,854,149 | 7,525 | Shares | Other | 2024-05-13 | |
| 2023-12-31 | $4,882,537 | 8,376 | Shares | Other | 2024-01-29 | |
| 2023-09-30 | $5,173,099 | 9,631 | Shares | Other | 2023-11-02 | |
| 2023-06-30 | $3,916,451 | 8,351 | Shares | Other | 2023-07-27 | |
| 2023-03-31 | $4,002,216 | 11,654 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $4,291,303 | 11,730 | Shares | Other | 2023-01-31 | |
| 2022-09-30 | $3,809,063 | 11,780 | Shares | Other | 2022-10-21 | |
| 2022-06-30 | $3,860,282 | 11,906 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $3,376,588 | 11,791 | Shares | Other | 2022-05-09 | |
| 2021-12-31 | $4,065,682 | 14,719 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $3,505,952 | 15,174 | Shares | Other | 2021-10-27 | |
| 2021-06-30 | $3,534,378 | 15,399 | Shares | Other | 2021-08-03 | |
| 2021-03-31 | $2,900,193 | 15,524 | Shares | Other | 2021-04-21 | |
| 2020-12-31 | $2,724,571 | 16,137 | Shares | Other | 2021-01-27 | |
| 2020-09-30 | $2,327,318 | 15,723 | Shares | Other | 2020-10-21 | |
| 2020-06-30 | $2,574,014 | 15,678 | Shares | Other | 2020-07-31 | |
| 2020-03-31 | $2,242,131 | 16,163 | Shares | Other | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||